Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015.
Anders EngelandTone BjørgeKari KlungsøyrVidar HjellvikSvetlana SkurtveitKari FuruPublished in: Pharmacoepidemiology and drug safety (2018)
The proportion of women using potentially teratogenic medications in the first trimester of pregnancy have increased during the last decade. Clinicians need to be aware of the possibility of pregnancy when prescribing potentially teratogenic medication to women of fertile age and focus this in the consultations. The increasing trends call for the need of routine surveillance of adverse birth outcomes linked to medication use in pregnancy.